PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
09-Feb-2022 Watson-Marlow launches industry first augmented reality app for Sine pump maintenance Sciad Newswire
09-Feb-2022 Eckert & Ziegler to Supply Telix with Lutetium-177 for Clinical Trials Eckert & Ziegler Strahlen- und Medizintechnik AG
08-Feb-2022 Xlife Sciences AG: Xlife Sciences publishes prospectus for listing on SIX Swiss Exchange Xlife Sciences AG
08-Feb-2022 Abivax to host Satellite Symposium at the 17th Congress of ECCO on Feb. 17, 2022 ABIVAX
08-Feb-2022 PharmaLex extends reach to Japan, East Asia and Southeast Asia with Ascent Development Services merger PharmaLex
08-Feb-2022 Sartorius completes acquisition of Novasep’s chromatography equipment division Novasep
08-Feb-2022 Strong 2021 sales and business EPS(1) growth enabling increased investment in R&D Sanofi
08-Feb-2022 SMC approves Angelini Pharma’s ONTOZRY®▼ (Cenobamate) for restricted use in adults with uncontrolled epilepsy in Scotland Angelini Pharma
08-Feb-2022 Freeline Presents on Its Fabry and Gaucher Disease AAV-Based Gene Therapies at the 18th Annual WORLDSymposiumTM Freeline Therapeutics Holdings plc
08-Feb-2022 The Scottish Medicines Consortium (SMC) approves diroximel fumarate as an oral treatment for relapsing-remitting multiple sclerosis (RRMS) Biogen UK
08-Feb-2022 Positive feedback from European Medicines Agency on XF-73 Nasal gel Phase 3 programme Destiny Pharma plc
08-Feb-2022 Top 3 Trends To Transform Orthopedic Devices Market Forecast Through 2027 Global Market Insights
08-Feb-2022 Koneksa Raises $45M Series C Financing to Accelerate Expansion of Digital Biomarker Platform Koneksa
08-Feb-2022 Jazz/GW Pharmaceuticals receives approval for the reimbursement of EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex in Scotland Jazz Pharmaceuticals plc
08-Feb-2022 FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Sanofi
08-Feb-2022 Kintara Therapeutics Announces Issuance of New US Patent Related to VAL-083 and MGMT Resistance: Implications for Targeting Brain Tumor Stem Cells Kintara Therapeutics
08-Feb-2022 AmerisourceBergen & Alliance Healthcare Executive Perspective Business Leaders on the Omicron Surge Alliance Healthcare
08-Feb-2022 Nanoform signs GMP manufacturing program with TargTex following formulation success Nanoform
08-Feb-2022 Tiziana Announces Submission of Amendment to Investigational New Drug Application to Advance Oral Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, in Patients with Crohn’s Disease Tiziana Life Sciences Ltd
08-Feb-2022 Empagliflozin (Jardiance®) receives positive NICE recommendation for the treatment of symptomatic chronic heart failure with reduced ejection fraction Boehringer Ingelheim